Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

Completed · Not applicable

Conditions studied: Smoking Cessation

In brief

The purpose of this clinical trial is to determine the feasibility and efficacy of an intervention designed to increase rates of tobacco abstinence for cancer patients before their cancer surgery.

Key facts

Study ID

NCT02402023

Run by

Yale University

People needed

40

Starts

2014-10-01

Expected to finish

2017-09-01

Last updated by the study team

2020-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 or older
• smoking ≥ 1 cigarettes per day
• CO > 6 ppm
• diagnosed with or suspicion of any type of operable thoracic, head and neck, breast, or gynecologic cancer
• agreement on a 2-5-week pre-surgical tobacco intervention by both patient and surgeon, and 6) residence within reasonable driving distance to New Haven.

You may not qualify if…

• unstable psychiatric conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia
• unstable medical conditions that have not been well controlled (e.g., acute infection requiring hospitalization) for the past 30 days
• pregnant or breastfeeding women
• those with limited decision making capacity.

Where it is running

• Yale Cancer Center — New Haven, Connecticut, United States
• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.